and then there’s the flu shot
the flu shot that many receive each year
must be continually updated
since the viruses that cause influenza are able to mutate quickly into new forms that aren’t as easily defeated by the antibodies developed in the previous year’s vaccine.
in a similar manner, because sars-cov-2 is able to evolve so quickly, the effectiveness of the initial vaccine is weakened, requiring more boosters and potentially, even an updated version. for this reason, researchers have been searching for a way to help the body develop antibodies against many different strains of the virus in a single vaccination while preparing the body for future strains as well.
the study
, published in science translational medicine at the end of december, tested the spfn vaccine in nonhuman primates. they found a two-shot series given 28 days apart caused the development of antibodies against sars-cov-2 and its variants of concern, as well as sars-cov-1.
data for this study was collected before the omicron variant took centre stage, and
the team is
currently testing the vaccine to see if it is still effective against this latest evolution.
phase 1 human trials for the spfn vaccine began in april 2021. early data from this trial is expected in the coming weeks.
on the hunt for a “universal” coronavirus vaccine
along with his team, director of the national institute of allergy and infectious diseases, dr. anthony fauci — who
previously called
the need for a yearly flu vaccine as “somewhat embarrassing” — has urged the global community to invest in developing universal coronavirus vaccines, and doing away with the yearly flu shot and the litany of covid boosters.